Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001730267 | SCV002401452 | benign | not provided | 2025-01-08 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001730267 | SCV004139716 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | RELB: BP4, BP7 |
Genome Diagnostics Laboratory, |
RCV001730267 | SCV001978321 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001730267 | SCV001980059 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003910984 | SCV004725722 | likely benign | RELB-related disorder | 2019-06-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |